Isrotel (TASE:ISRO) Could Be Overvalued As Q2 Earnings Improve

Isrotel (TASE:ISRO) just released second quarter 2026 earnings, reporting net income of ₪81.73 million and basic earnings per share of ₪1.44 from continuing operations, compared with the same period last year.

The latest results arrive after a mixed share price run for Isrotel. The stock is trading at ₪128.0, with a 1-day share price return of 4.06% and a 7-day share price return of 8.02%, contrasting with a year-to-date share price decline of 20.25%. The 5-year total shareholder return of 72.77% points to stronger long-term compounding for investors.

Spot opportunities beyond Isrotel's latest earnings and compare this hotel operator with a curated 267 high quality undervalued stocks that may offer similar or stronger long-term compounding potential.

After a sharp weekly rebound but a weaker year so far, Isrotel now sits at an interesting crossroads. Has most of the easy upside already played out? Or does the current price still leave meaningful room ahead?

Preferred P/E of 29.6x: Is it justified?

On simple numbers, Isrotel trades on a P/E of 29.6x at a share price of ₪128, which looks expensive compared with both its industry and peer group.

The P/E ratio compares the current share price with earnings per share. For a hotel operator like Isrotel, it gives a quick read on how much investors are paying for each unit of current earnings, in a sector where profitability can be cyclical and sensitive to travel demand.

Here, the premium is clear. Isrotel's P/E of 29.6x is materially higher than the Asian hospitality industry average of 19.7x and also above the peer average of 11.4x. That spread suggests the market is assigning a richer price to the company than it does to many regional and size-based comparables.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-earnings of 29.6x (OVERVALUED)

However, the Isrotel story can shift quickly if travel demand weakens or if higher costs pressure margins, which could challenge the current premium P/E multiple.

Find out about the key risks to this Isrotel narrative.

Another view on Isrotel using our DCF model

The SWS DCF model presents a very different picture for Isrotel. At a share price of ₪128, the stock is trading well above an estimated future cash flow value of ₪29.58. On this view, the shares appear expensive rather than supported by underlying cash generation.

For investors, the gap between price and this cash flow based estimate highlights valuation risk. It raises a simple question: Is the market correctly pricing long term prospects, or has enthusiasm pushed Isrotel too far ahead of the cash flows that the business is currently expected to generate?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Isrotel for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 267 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Looking for more investment ideas beyond Isrotel?

Isrotel's latest numbers give useful context, but your portfolio benefits when you keep scanning for fresh opportunities that match different goals and risk levels.

Use the Simply Wall St screener to quickly surface stocks that fit specific traits before the crowd catches on.

• Target resilience first by reviewing a 313 resilient stocks with low risk scores that focuses on companies with more stable risk profiles and potentially smoother return paths.
• Hunt for quality at a discount through a curated 616 high quality undiscovered gems that highlights strong fundamentals which the market may not be fully pricing yet.
• Strengthen your core holdings by scanning a list of solid balance sheet and fundamentals (427 results) that focuses on companies with sturdier finances and healthier balance sheets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com